The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype

  1. Vinué, Á.
  2. Navarro, J.
  3. Herrero-Cervera, A.
  4. García-Cubas, M.
  5. Andrés-Blasco, I.
  6. Martínez-Hervás, S.
  7. Real, J.T.
  8. Ascaso, J.F.
  9. González-Navarro, H.
Journal:
Diabetologia

ISSN: 1432-0428,  0012-186X

Year of publication: 2017

Volume: 60

Issue: 9

Pages: 1801-1812

Type: Article

DOI: 10.1007/S00125-017-4330-3 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus